IP Library Granted Patent US 8,865,924
Granted Patent B2
US 8,865,924 · App. 13/912,508 · Granted Oct 21, 2014

Compounds for use as ligands

Inventors: John Blacker (Leeds, GB); Kevin Treacher (Manchester, GB); Thomas Screen (Manchester, GB)
Assignee: University of Leeds
B01J31/2295C07F17/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,924
App. No.
13/912,508
Granted
Oct 21, 2014
Kind
B2
Abstract

The present invention relates to compounds and their use as ligands, in particular, in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.

Claims (32)

1. A metal complex comprising a metal and one or more ligands, wherein the metal is selected from the group consisting of rhodium, iridium, platinum, palladium, titanium, ruthenium and cobalt and at least one of the ligands is a compound of the formula (I):

wherein

R 1 is a cyclopentadienyl group;

X is an alkylene linker comprising at least two in-chain carbon atoms; and

Y is selected from the group consisting of ═O, —OH, ═S, —SH, —S(O), —S(O) 2 , NH 2 , amino or mono-substituted amino.

2. The metal complex according to claim 1 , wherein the compound is not selected from the group consisting of 1-(3-hydroxypropyl)-2,3,4,5-tetramethylcyclopentadiene, 1-(4-hydroxy butyl)-2,3,4,5-tetramethylcyclopentadiene, 1-(5-hydroxypentyl)-2,3,4,5-tetramethylcyclo pentadiene, 1-(3-aminopropyl)-2,3,4,5-tetramethytcyclopentadiene, 1-(4-aminobutyl)-2,3,4,5-tetramethylcyclopentadiene, 1-(5-aminopentyl)-2,3,4,5-tetramethylcyclopentadiene and 1-(8-heptadecenyl)2,3,4,5-tetramethylcyclopentadiene.

3. The metal complex according to claim 1 , wherein R 1 is tetramethylcyclopentadienyl.

4. The metal complex according to claim 1 , wherein X has 2 to 20 in-chain carbon atoms.

5. The metal complex according to claim 1 , wherein X is an alkenylene group.

6. The metal complex according to claim 2 , wherein Y is selected from the group consisting of ═O, —OH and —NH 2 .

7. The metal complex according to claim 1 , wherein Y is a mono-substituted amino group.

8. The metal complex according to claim 7 , wherein the amino group is substituted with a substituted C 1-6 alkyl, aryl, arylalkyl or heteroaryl group.

9. The metal complex according to claim 7 , wherein the mono-substituted amino group is N—(C 1-6 alkyl)amino, amino or tosyl amino.

10. The metal complex according to claim 1 , wherein the X and/or Y is selected from the group consisting of 2-hydroxyethyl, 3-hydroxy-n-propyl, 4-hydroxy-n-pentyl, 2-hydroxypropyl, 3-hydroxybutyl, 3-hydroxy-1-methylpropyl, 1-methylene-3-hydroxypropyl, 3-hydroxy-3-phenylpropyl, 2-oxopropyl, 3-oxobutyl, 4-oxopentyl, 3-aminopropyl, 5-aminopentyl, 3-propanoate and 5-pentanoate.

11. The metal complex according to claim 1 , wherein the metal is a transition metal.

12. The metal complex according to claim 1 , wherein the metal is rhodium or iridium.

13. The metal complex according to claim 1 , wherein the metal complex comprises one or more additional ligands.

14. A process for production of a metal complex comprising a metal and one or more ligands, the metal is selected from the group consisting of rhodium, iridium, platinum, palladium, titanium, ruthenium and cobalt and at least one of the ligands is a compound of formula (I):

wherein

R 1 is a cyclopentadienyl group;

X is an alkylene linker comprising at least two in-chain carbon atoms; and

Y is selected from the group consisting of ═O, —OH, ═S, —SH, —S(O), —S(O) 2 , amino and mono-substituted amino, wherein the process comprises

i) contacting a compound of formula (III):

wherein

X is an alkylene linker comprising at least two in-chain carbon atoms;

Y is selected from the group consisting of ═O, —OH, ═S, —SH, —S(O), —S(O) 2 , amino and mono-substituted amino;

each R 2 is independently an ethenyl group;

with an acid under conditions such that the R 2 groups and the carbon atom to which they are attached together form a cyclopentadienyl group; and

ii) contacting the compound of formula (I) with a metal to form the metal complex.

15. The metal complex according to claim 1 , further comprising a catalyst.

16. The metal complex according to claim 7 , wherein the amino group is substituted with a hydrocarbyl group, a heterocyclyl group or a heterocycloalkyl group.

17. The metal complex according to claim 16 , wherein the hydrocarbyl group, heterocyclyl group or heterocycloalkyl group are optionally attached to the nitrogen atom of the amino group via a linkage selected from the group consisting of —O—, C(O)—, —C(O)O—, —S—, —S(O)— and —S(O) 2 —.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2013
From: PIRAMAL HEALTHCARE UK LIMITED
To: UNIVERSITY OF LEEDS
Reel/Frame 030736/0453 →
CHANGE OF NAME Recorded Jul 3, 2013
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 030747/0478 →
Priority Claims (1)
GB 0801319.5 · Jan 25, 2008 · national
Continuity (2)
Continuation 12864402
Related Publication 20130267725A1 · Oct 10, 2013